Literature DB >> 31967039

OVARIAN GRANULOSA CELL TUMOR IN A PATIENT WITH A PATHOGENIC VARIANT IN THE CDC73 GENE (HYPERPARATHYROIDISM-JAW TUMOR SYNDROME).

Rowella Licup Sirbiladze, Denise Uyar, Jennifer L Geurts, Joseph L Shaker.   

Abstract

OBJECTIVE: To report a patient with the hyperparathyroidism-jaw tumor syndrome (HPT-JT) who was found to have a rare ovarian tumor (granulosa cell tumor [GCT]). HPT-JT is caused by pathogenic variants in the CDC73 gene and results in primary hyperparathyroidism (PHPT), benign fibro-osseous jaw tumors, benign or malignant renal tumors and cysts, and benign or malignant uterine tumors. We believe this is the first reported case of HPT-JT and GCT.
METHODS: The patient was a 31-year-old woman with abdominal pain who was found to have adult GCT. Her history was significant for a single gland parathyroidectomy at age 23 for PHPT. Her mother also had PHPT with 1-gland removal, as well as a history of renal cysts. Because of the personal and familial history of PHPT, she underwent germline sequencing of genes associated with PHPT including CASR, CDC73, CDKN1B, MEN1 and RET.
RESULTS: Genetic testing revealed a CDC73 gene pathogenic variant (c.687_688dupAG) which creates a premature translational stop signal causing loss-of-function.
CONCLUSION: We report a case of ovarian GCT in a young patient with primary hyperparathyroidism and a CDC73 gene mutation. Ovarian granulosa cell tumor may be another CDC73-related tumor.
Copyright © 2019 AACE.

Entities:  

Year:  2019        PMID: 31967039      PMCID: PMC6876943          DOI: 10.4158/ACCR-2018-0555

Source DB:  PubMed          Journal:  AACE Clin Case Rep        ISSN: 2376-0605


  19 in total

1.  Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance.

Authors:  Vito Guarnieri; Alfredo Scillitani; Lucia Anna Muscarella; Claudia Battista; Nazzareno Bonfitto; Michele Bisceglia; Salvatore Minisola; Maria Lucia Mascia; Leonardo D'Agruma; David E C Cole
Journal:  J Clin Endocrinol Metab       Date:  2006-05-23       Impact factor: 5.958

2.  Mutation of FOXL2 in granulosa-cell tumors of the ovary.

Authors:  Sohrab P Shah; Martin Köbel; Janine Senz; Ryan D Morin; Blaise A Clarke; Kimberly C Wiegand; Gillian Leung; Abdalnasser Zayed; Erika Mehl; Steve E Kalloger; Mark Sun; Ryan Giuliany; Erika Yorida; Steven Jones; Richard Varhol; Kenneth D Swenerton; Dianne Miller; Philip B Clement; Colleen Crane; Jason Madore; Diane Provencher; Peter Leung; Anna DeFazio; Jaswinder Khattra; Gulisa Turashvili; Yongjun Zhao; Thomas Zeng; J N Mark Glover; Barbara Vanderhyden; Chengquan Zhao; Christine A Parkinson; Mercedes Jimenez-Linan; David D L Bowtell; Anne-Marie Mes-Masson; James D Brenton; Samuel A Aparicio; Niki Boyd; Martin Hirst; C Blake Gilks; Marco Marra; David G Huntsman
Journal:  N Engl J Med       Date:  2009-06-10       Impact factor: 91.245

3.  Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.

Authors:  Anthony J Gill; Adele Clarkson; Oliver Gimm; Juliane Keil; Henning Dralle; Viive M Howell; Deborah J Marsh
Journal:  Am J Surg Pathol       Date:  2006-09       Impact factor: 6.394

4.  Fibroosseous tumors of the facial skeleton in association with primary hyperparathyroidism: an endocrine syndrome or coincidence?

Authors:  I B Rosen; J A Palmer
Journal:  Am J Surg       Date:  1981-10       Impact factor: 2.565

5.  HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.

Authors:  J D Carpten; C M Robbins; A Villablanca; L Forsberg; S Presciuttini; J Bailey-Wilson; W F Simonds; E M Gillanders; A M Kennedy; J D Chen; S K Agarwal; R Sood; M P Jones; T Y Moses; C Haven; D Petillo; P D Leotlela; B Harding; D Cameron; A A Pannett; A Höög; H Heath; L A James-Newton; B Robinson; R J Zarbo; B M Cavaco; W Wassif; N D Perrier; I B Rosen; U Kristoffersson; P D Turnpenny; L-O Farnebo; G M Besser; C E Jackson; H Morreau; J M Trent; R V Thakker; S J Marx; B T Teh; C Larsson; M R Hobbs
Journal:  Nat Genet       Date:  2002-11-18       Impact factor: 38.330

6.  Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas.

Authors:  B T Teh; F Farnebo; U Kristoffersson; B Sundelin; J Cardinal; R Axelson; A Yap; M Epstein; H Heath; D Cameron; C Larsson
Journal:  J Clin Endocrinol Metab       Date:  1996-12       Impact factor: 5.958

7.  Familial cystic parathyroid adenomatosis.

Authors:  L E Mallette; S Malini; M P Rappaport; J L Kirkland
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

Review 8.  Endocrine neoplasms in familial syndromes of hyperparathyroidism.

Authors:  Yulong Li; William F Simonds
Journal:  Endocr Relat Cancer       Date:  2016-05-20       Impact factor: 5.678

9.  Hyperparathyroidism-jaw tumour syndrome.

Authors:  J D Chen; C Morrison; C Zhang; K Kahnoski; J D Carpten; B T Teh
Journal:  J Intern Med       Date:  2003-06       Impact factor: 8.989

10.  The roles of parafibromin expression in ovarian epithelial carcinomas: a marker for differentiation and prognosis and a target for gene therapy.

Authors:  Dao-Fu Shen; Xin Liu; Xue-Feng Yang; Lei Fang; Yang Gao; Shuang Zhao; Ji-Cheng Wu; Shuai Shi; Jun-Jun Li; Xiang-Xuan Zhao; Wen-Feng Gou; Hua-Chuan Zheng
Journal:  Tumour Biol       Date:  2015-09-26
View more
  1 in total

1.  Hyperparathyroidism-Jaw Tumor Syndrome.

Authors:  Travis D Weaver; Mohamed K M Shakir; Thanh D Hoang
Journal:  Case Rep Oncol       Date:  2021-02-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.